How is pneumonia prevented in immunocompromised patients?

Updated: Jan 07, 2019
  • Author: Julie B Zhao, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print


Optimization of treatment of the underlying immunocompromise is a first approach to prevention of pneumonia in immunocompromised individuals. This includes HAART, chemo and radiation therapy, and other measures depending on the type of immunocompromise.

However, despite optimal therapy, prevention of opportunistic and endemic pulmonary infections can be difficult.

Vaccination against pneumococcal and influenza, as well as prophylaxis against bacteria, viruses, and fungi, are other methods of prevention.

In rheumatologic disorders in which corticosteroids and/or immunomodulators such as TNF-inhibitors play a role in symptom control, the optimization of the level of immunosuppression is as important as prophylaxis against microbial infection.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!